cfDNA Extraction from Plasma (Round 2)

Three artificial plasma samples (4ml) designed to mimic patient samples will be provided for cfDNA extraction. 

The samples are manufactured for EMQN CIC by SensID GmbH (https://www.sens-id.com). Separate nucleosomal ctDNA controls are available from SensID GmbH directly. Inclusion herein does not represent an endorsement of their product or service by EMQN CIC.  

Participants will receive an individual report including educational advice and a scheme report which includes additional information from the cohort of participants including geographical spread, methodologies employed, common errors, learning points and scheme statistics allowing participants to benchmark their results.

Each laboratory will also receive a single certificate listing all EQAs participated in with performance result for each year.

Participants are expected to extract cfDNA from the samples according to their routine strategy. Participants are responsible for returning the extracted cfDNA in tubes and packaging provided by EMQN and must complete the data collection form.

This EQA is supported by an educational grant from AstraZeneca, fees are subsidised so there is a no cost for participants. EMQN would like to acknowledge and thank AstraZeneca for this support.

Participation is limited, please register early to avoid disappointment. Open to laboratories from ALL countries (note: some restrictions may apply due to sanctions, delivery network exceptions, restrictions on importation etc).